Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  2. 8-K Event Unregistered share sale · Other events
  3. 8-K Event Results of operations
  4. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  5. 8-K Event Executive or director change
  6. 8-K Event Other events
  7. 8-K Event Results of operations
  8. 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
  9. 8-K Event Shareholder vote results
  10. 8-K Event Results of operations
  11. DEF 14A Proxy Proxy Statement
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. 8-K Event Executive or director change · Regulation FD disclosure
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change
  17. 8-K Event Results of operations
  18. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  19. 8-K Event Results of operations
  20. DEF 14A Proxy Proxy Statement

Page 1 of 16 · 318 filings